Serofendic acid prevents 6-hydroxydopamine-induced nigral neurodegeneration and drug-induced rotational asymmetry in hemi-parkinsonian rats. [electronic resource]
Producer: 20060120Description: 950-61 p. digitalISSN:- 0022-3042
- Adrenergic Agents
- Aldehydes -- metabolism
- Animals
- Behavior, Animal
- Blotting, Western -- methods
- CD11b Antigen -- metabolism
- Cell Count -- methods
- Cell Line
- Disease Models, Animal
- Diterpenes -- therapeutic use
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Interactions
- Functional Laterality
- Glial Fibrillary Acidic Protein -- metabolism
- Humans
- Immunohistochemistry -- methods
- Male
- Neurodegenerative Diseases -- chemically induced
- Neuroprotective Agents -- therapeutic use
- Oxidopamine
- Parkinson Disease, Secondary -- chemically induced
- Parkinsonian Disorders -- drug therapy
- Rats
- Rats, Wistar
- Reactive Oxygen Species -- metabolism
- Rotarod Performance Test -- methods
- Rotation
- Substantia Nigra -- drug effects
- Synaptophysin -- metabolism
- Time Factors
- Tyrosine -- analogs & derivatives
- Tyrosine 3-Monooxygenase -- metabolism
- alpha-Synuclein -- metabolism
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.